Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216

Generalized lacZ expression with the ROSA26 Cre reporter strain

Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237

Narcolepsy in orexin Knockout Mice

Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083

Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB

Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,055

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555

Pten Regulates Neuronal Arborization and Social Interaction in Mice

Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970

Akt regulates growth by directly phosphorylating Tsc2

Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959

Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis

Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882

Dendritic spine pathology in neuropsychiatric disorders

Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523

Behavioural phenotyping assays for mouse models of autism

Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462

Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice

Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., Steinberg, J., Crawley, J. N., Regehr, W. G., & Sahin, M. (2012) · Nature · doi:10.1038/nature11310 · Cited by 888

Advancing the understanding of autism disease mechanisms through genetics

de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827

Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles

Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842

Proliferative Neural Stem Cells Have High Endogenous ROS Levels that Regulate Self-Renewal and Neurogenesis in a PI3K/Akt-Dependant Manner

Le Belle, J. E., Orozco, N. M., Paucar, A. A., Saxe, J. P., Mottahedeh, J., Pyle, A. D., Wu, H., & Kornblum, H. I. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.028 · Cited by 789

Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities

Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797

The Neurology of mTOR

Lipton, J. O., & Şahin, M. (2014) · Neuron · doi:10.1016/j.neuron.2014.09.034 · Cited by 771

A synaptic trek to autism

Bourgeron, T. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.06.003 · Cited by 637

Mechanisms of epileptogenesis and potential treatment targets

Pitkänen, A., & Łukasiuk, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70310-0 · Cited by 614

Automated Three‐Chambered Social Approach Task for Mice

Yang, M., Silverman, J. L., & Crawley, J. N. (2011) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0826s56 · Cited by 598

Autism-related deficits via dysregulated eIF4E-dependent translational control

Gkogkas, C. G., Khoutorsky, A., Ran, I., Rampakakis, E., Nevarko, T., Weatherill, D. B., Vasuta, C., Yee, S., Truitt, M., Dallaire, P., et al. (2013) · Nature · doi:10.1038/nature11628 · Cited by 522

Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders

Lee, E., Lee, J., & Kim, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.011 · Cited by 468

Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects

Kim, H.-J., Cho, M.-H., Shim, W. H., Kim, J. K., Jeon, E.-Y., Kim, D.-H., & Yoon, S.-Y. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.103 · Cited by 475

Rapamycin Protects against Neuron Death inIn VitroandIn VivoModels of Parkinson's Disease

Malagelada, C., Jin, Z. H., Jackson-Lewis, V. R., Przedborski, S., & Greene, L. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 465

Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEP

Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438

mTOR complexes in neurodevelopmental and neuropsychiatric disorders

Costa-Mattioli, M., & Monteggia, L. M. (2013) · Nature Neuroscience · doi:10.1038/nn.3546 · Cited by 367

Exaggerated translation causes synaptic and behavioural aberrations associated with autism

Santini, E., Huynh, T. N., MacAskill, A. F., Carter, A. G., Pierre, P., Ruggero, D., Kaphzan, H., & Klann, E. (2012) · Nature · doi:10.1038/nature11782 · Cited by 383

Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB

Polito, V. A., Li, H., Martini‐Stoica, H., Wang, B., Li, Y., Xu, Y., Swartzlander, D. B., Palmieri, M., di Ronza, A., Lee, V. M. ‐., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303671 · Cited by 356

mTOR in Brain Physiology and Pathologies

Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 381

Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias

D’Gama, A. M., Woodworth, M. B., Hossain, A. A., Bizzotto, S., Hatem, N. E., LaCoursiere, C. M., Najm, I., Ying, Z., Yang, E., Barkovich, A. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.106 · Cited by 333

DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212

Kim, J. Y., Duan, X., Liu, C. Y., Jang, M.-H., Guo, J. U., Pow-anpongkul, N., Kang, E., Song, H., & Ming, G.-L. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.008 · Cited by 319

mTORC2 controls actin polymerization required for consolidation of long-term memory

Huang, W., Zhu, P. J., Zhang, S., Zhou, H., Stoica, L., Galiano, M., Krnjević, K., Roman, G., & Costa-Mattioli, M. (2013) · Nature Neuroscience · doi:10.1038/nn.3351 · Cited by 307

The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders

Betancur, C., Sakurai, T., & Buxbaum, J. D. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.04.003 · Cited by 304

Local RNA Translation at the Synapse and in Disease: Figure 1.

Liu‐Yesucevitz, L., Bassell, G. J., Gitler, A. D., Hart, A. C., Klann, E., Richter, J. D., Warren, S. T., & Wolozin, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4105-11.2011 · Cited by 296

Lessons learned from studying syndromic autism spectrum disorders

Sztainberg, Y., & Zoghbi, H. Y. (2016) · Nature Neuroscience · doi:10.1038/nn.4420 · Cited by 305

Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy

Pun, R. Y. K., Rolle, I. J., LaSarge, C. L., Hosford, B. E., Rosen, J. M., Uhl, J. D., Schmeltzer, S. N., Faulkner, C., Bronson, S. L., Murphy, B. L., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.002 · Cited by 266

Past and Present Definitions of Epileptogenesis and Its Biomarkers

Pitkänen, A., & Engel, J. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0257-2 · Cited by 265

Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications

Jiang, C.-C., Lin, L., Long, S., Ke, X., Fukunaga, K., Lu, Y., & Han, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01081-0 · Cited by 295

Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome

Krueger, D. D., & Bear, M. F. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-061109-134644 · Cited by 259

The Emerging Picture of Autism Spectrum Disorder: Genetics and Pathology

Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V., & Geschwind, D. H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040405 · Cited by 254

Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism

Silverman, J. L., Smith, D. G., Rizzo, S. J. S., Karras, M. N., Turner, S. M., Tolu, S. S., Bryce, D. K., Smith, D. L., Fonseca, K., Ring, R. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003501 · Cited by 251

Autophagy in acute brain injury

Galluzzi, L., Bravo-San Pedro, J. M., Blomgren, K., & Kroemer, G. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.51 · Cited by 234

Rapamycin Suppresses Mossy Fiber Sprouting But Not Seizure Frequency in a Mouse Model of Temporal Lobe Epilepsy

Buckmaster, P. S., & Lew, F. H. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4852-10.2011 · Cited by 243

The Role of Iron in Learning and Memory

Fretham, S. J. B., Carlson, E. S., & Georgieff, M. K. (2011) · Advances in Nutrition · doi:10.3945/an.110.000190 · Cited by 235

Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex

Zeng, L.-H., Rensing, N. R., Zhang, B., Gutmann, D. H., Gambello, M. J., & Wong, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq491 · Cited by 233

Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy

Huang, X., Zhang, H., Yang, J., Wu, J., McMahon, J. J., Lin, Y., Cao, Z., Gruenthal, M., & Huang, Y. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.024 · Cited by 231

Progress toward treatments for synaptic defects in autism

Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., & Bourgeron, T. (2013) · Nature Medicine · doi:10.1038/nm.3193 · Cited by 218

Translational animal models of autism and neurodevelopmental disorders

Crawley, J. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/jcrawley · Cited by 236

Abnormal mTOR Activation in Autism

Winden, K. D., Ebrahimi‐Fakhari, D., & Şahin, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061747 · Cited by 232

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy

Tan, C., Yu, J., Tan, M., Jiang, T., Zhu, X., & Tan, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.019 · Cited by 224

Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex

Sato, A., Kasai, S., Kobayashi, T., Takamatsu, Y., Hino, O., Ikeda, K., & Mizuguchi, M. (2012) · Nature Communications · doi:10.1038/ncomms2295 · Cited by 229

Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function

Biever, A., Valjent, E., & Puighermanal, E. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00075 · Cited by 227

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders

Ehninger, D., & Silva, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.002 · Cited by 223

Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies.

Wong, M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02341.x · Cited by 205

Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management

de Theije, C. G. M., Wu, J., da Silva, S. L., Kamphuis, P. J. G. H., Garssen, J., Korte, S. M., & Kraneveld, A. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.013 · Cited by 212

PTEN signaling in autism spectrum disorders

Zhou, J., & Parada, L. F. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.05.004 · Cited by 188

Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation

LaSarge, C. L., & Danzer, S. C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00018 · Cited by 202

Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex

MacKeigan, J. P., & Krueger, D. A. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov152 · Cited by 185

Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism

Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2656-15.2015 · Cited by 167

Behavioral phenotypes of genetic mouse models of autism

Kazdoba, T. M., Leach, P. T., & Crawley, J. N. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12256 · Cited by 187

Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism

Frazier, T. W., Embacher, R., Tilot, A. K., Koenig, K., Mester, J., & Eng, C. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.125 · Cited by 177

Pten Deletion in Adult Hippocampal Neural Stem/Progenitor Cells Causes Cellular Abnormalities and Alters Neurogenesis

Amiri, A., Cho, W., Zhou, J., Birnbaum, S. G., Sinton, C. M., McKay, R. M., & Parada, L. F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5462-11.2012 · Cited by 175

Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics

Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5003 · Cited by 185

Genetics of glutamate and its receptors in autism spectrum disorder

Nisar, S., Bhat, A. A., Masoodi, T., Hashem, S., Akhtar, S., Ali, T. A., Amjad, S., Chawla, S., Bagga, P., Frenneaux, M. P., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01506-w · Cited by 189

Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases

Wong, M. (2013) · Biomedical Journal · doi:10.4103/2319-4170.110365 · Cited by 173

Therapeutic approaches to epileptogenesis—Hope on the horizon

Pitkänen, A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02602.x · Cited by 175

Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways

Borrie, S. C., Brems, H., Legius, E., & Bagni, C. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035332 · Cited by 169

Role of mTOR Complexes in Neurogenesis

Licausi, F., & Hartman, N. W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051544 · Cited by 172

mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis

Citraro, R., Leo, A., Constanti, A., Russo, E., & Sarro, G. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.039 · Cited by 165

Behavioral profiles of mouse models for autism spectrum disorders

Ey, E., Leblond, C. S., & Bourgeron, T. (2011) · Autism Research · doi:10.1002/aur.175 · Cited by 166

Dysregulation of the IGF‐I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders

Chen, J., Alberts, I., & Li, X. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.03.006 · Cited by 151

Roles of mTOR Signaling in Brain Development

Lee, D. Y. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.3.177 · Cited by 172

Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target

Galanopoulou, A. S., Gorter, J. A., & Cepeda, C. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03506.x · Cited by 158

Impaired Autophagy in Neurons after Disinhibition of Mammalian Target of Rapamycin and Its Contribution to Epileptogenesis

McMahon, J. J., Huang, X., Yang, J., Komatsu, M., Yue, Z., Qian, J., Zhu, X. C., & Huang, Y. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2392-12.2012 · Cited by 156

Cellular phenotypes in human iPSC-derived neurons from a genetic model of autism spectrum disorder

Deshpande, A., Yadav, S., Dao, D. Q., Wu, Z.-Y., Hokanson, K. C., Cahill, M. K., Wiita, A. P., Jan, Y.-N., Ullian, E. M., & Weiss, L. A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.037 · Cited by 151

Role for mTOR Signaling and Neuronal Activity in Morphine-Induced Adaptations in Ventral Tegmental Area Dopamine Neurons

Mazei‐Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, M., Krishnan, V., Kim, S., Siuta, M., Galli, A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.10.012 · Cited by 148

Pten KnockdownIn VivoIncreases Excitatory Drive onto Dentate Granule Cells

Luikart, B. W., Schnell, E., Washburn, E. K., Bensen, A. L., Tovar, K. R., & Westbrook, G. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0061-11.2011 · Cited by 141

A pulse rapamycin therapy for infantile spasms and associated cognitive decline

Raffo, E., Coppola, A., Ono, T., Briggs, S. W., & Galanopoulou, A. S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.021 · Cited by 140

mTOR signaling for biological control and cancer

Alayev, A., & Holz, M. K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24351 · Cited by 143

Genetic aspects of autism spectrum disorders: insights from animal models

Banerjee, S., Riordan, M., & Bhat, M. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00058 · Cited by 156

A Metabolic Roadmap for Somatic Stem Cell Fate

Ly, C., Lynch, G. S., & Ryall, J. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.022 · Cited by 144

Megalencephaly and hemimegalencephaly: Breakthroughs in molecular etiology

Mirzaa, G., & Poduri, A. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31401 · Cited by 136

Hyperactivity of Newborn Pten Knock-out Neurons Results from Increased Excitatory Synaptic Drive

Williams, M. R., DeSpenza, T., Li, M., Gulledge, A. T., & Luikart, B. W. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3144-14.2015 · Cited by 133

The Parvalbumin/Somatostatin Ratio Is Increased in Pten Mutant Mice and by Human PTEN ASD Alleles

Vogt, D. L., Cho, K. K. A., Lee, A. T., Sohal, V. S., & Rubenstein, J. L. R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.019 · Cited by 135

Hyperconnectivity of prefrontal cortex to amygdala projections in a mouse model of macrocephaly/autism syndrome

Huang, W.-C., Chen, Y., & Page, D. T. (2016) · Nature Communications · doi:10.1038/ncomms13421 · Cited by 130

Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future

Silverman, J. L., Thurm, A. E., Ethridge, S. B., Soller, M. M., Petkova, S. P., Abel, T. G., Bauman, M. D., Brodkin, E. S., Harony‐Nicolas, H., Wöhr, M., et al. (2022) · Genes Brain & Behavior · doi:10.1111/gbb.12803 · Cited by 133

Networking in Autism: Leveraging Genetic, Biomarker and Model System Findings in the Search for New Treatments

Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128

Annual Research Review: The state of autism intervention science: progress, target psychological and biological mechanisms and future prospects

Green, J., & Garg, S. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12892 · Cited by 138

Role of the mTOR signaling pathway in epilepsy

Meng, X., Yu, J., Song, J., Chi, S., & Tan, L. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.029 · Cited by 127

Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders

Stamou, M., Streifel, K. M., Goines, P. E., & Lein, P. J. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.12.001 · Cited by 128

Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism

Takeuchi, K., Gertner, M. J., Zhou, J., Parada, L. F., Bennett, M. V. L., & Zukin, R. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222803110 · Cited by 124

Role of Oligodendrocytes and Myelin in the Pathophysiology of Autism Spectrum Disorder

Gálvez‐Contreras, A. Y., Zárate-López, D., Torres-Chávez, A. L., & González-Pérez, Ó. (2020) · Brain Sciences · doi:10.3390/brainsci10120951 · Cited by 131

GABAergic Interneuron Development and Function Is Modulated by the Tsc1 Gene

Fu, C., Cawthon, B., Clinkscales, W. B., Bruce, A., Winzenburger, P. A., & Ess, K. C. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr300 · Cited by 126

Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice

Sunnen, C. N., Brewster, A. L., Lugo, J. N., Vanegas, F., Turcios, E., Mukhi, S., Parghi, D., D’Arcangelo, G., & Anderson, A. E. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03280.x · Cited by 122

A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials

Wong, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.48 · Cited by 123

Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency

Chen, C.-J., Sgritta, M., Mays, J., Zhou, H., Lucero, R., Park, J., Wang, I.-C., Park, J. H., Kaipparettu, B. A., Stoica, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0608-y · Cited by 119

Multiple Roles for Mammalian Target of Rapamycin Signaling in Both Glutamatergic and GABAergic Synaptic Transmission

Weston, M. C., Chen, H., & Swann, J. W. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1283-12.2012 · Cited by 125

Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders

Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118

Mitochondrial Dysfunction in Pten Haplo-Insufficient Mice with Social Deficits and Repetitive Behavior: Interplay between Pten and p53

Napoli, E., Ross‐Inta, C., Wong, S., Hung, C., Fujisawa, Y., Sakaguchi, D., Angelastro, J. M., Omanska-Klusek, A., Schoenfeld, R. A., & Giulivi, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042504 · Cited by 116

Spinal Cord Regeneration

Kwon, B. K., & Tetzlaff, W. (2001) · Spine · doi:10.1097/00007632-200112151-00003 · Cited by 116

Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy

Clossen, B. L., & Reddy, D. S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.003 · Cited by 117

N ‐acetyl‐ L ‐cysteine protects against cadmium‐induced neuronal apoptosis by inhibiting ROS ‐dependent activation of A kt/m TOR pathway in mouse brain

Chen, S., Ren, Q., Zhang, J., Ye, Y., Zhang, Z., Xu, Y., Guo, M., Ji, H., Xu, C., Gu, C., et al. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12103 · Cited by 113

mTOR, a Potential Target to Treat Autism Spectrum Disorder

Sato, A. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120638 · Cited by 117

Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage

Brewster, A. L., Lugo, J. N., Patil, V. V., Lee, W. L., Qian, Y., Vanegas, F., & Anderson, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057808 · Cited by 112

High‐dose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy

Heng, K., Haney, M. M., & Buckmaster, P. S. (2013) · Epilepsia · doi:10.1111/epi.12246 · Cited by 112

Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target

Mukhtar, I. (2020) · Seizure · doi:10.1016/j.seizure.2020.09.015 · Cited by 120

Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes

Spinelli, L., Black, F., Berg, J. N., Eickholt, B. J., & Leslie, N. R. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102803 · Cited by 110

Autism spectrum disorders: The quest for genetic syndromes

Zafeiriou, D., Ververi, A., Dafoulis, V., Kalyva, E., & Vargìami, E. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32152 · Cited by 116

Social peers rescue autism‐relevant sociability deficits in adolescent mice

Yang, M., Perry, K., Weber, M. D., Katz, A. M., & Crawley, J. N. (2011) · Autism Research · doi:10.1002/aur.163 · Cited by 106

Disruption of mTORC1 rescues neuronal overgrowth and synapse function dysregulated by Pten loss

Tariq, K., Cullen, E. R., Getz, S. A., Conching, A., Goyette, A. R., Prina, M. L., Wang, W., Li, M., Weston, M. C., & Luikart, B. W. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111574 · Cited by 58

Rapamycin improves social and stereotypic behavior abnormalities induced by pre‐mitotic neuronal subset specific Pten deletion

Narvaiz, D. A., Nolan, S. O., Smith, G. D., Holley, A. J., Reynolds, C. D., Blandin, K. J., Nguyen, P. H., Tran, D. L. K., & Lugo, J. N. (2023) · Genes Brain & Behavior · doi:10.1111/gbb.12854 · Cited by 9

Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency

Chen, C.-J., Sgritta, M., Mays, J., Zhou, H., Lucero, R., Park, J., Wang, I.-C., Park, J. H., Kaipparettu, B. A., Stoica, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0608-y · Cited by 119

Deleting PTEN for better or worse

Welberg, L. (2009) · Nature reviews. Neuroscience · doi:10.1038/nrn2625

mTORC2 Steals the Spotlight

Jansen, L. A. (2020) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759720905835 · Cited by 1